Jing Dai

410 total citations
26 papers, 294 citations indexed

About

Jing Dai is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Jing Dai has authored 26 papers receiving a total of 294 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 13 papers in Cancer Research and 3 papers in Oncology. Recurrent topics in Jing Dai's work include MicroRNA in disease regulation (10 papers), Circular RNAs in diseases (7 papers) and Cancer-related molecular mechanisms research (7 papers). Jing Dai is often cited by papers focused on MicroRNA in disease regulation (10 papers), Circular RNAs in diseases (7 papers) and Cancer-related molecular mechanisms research (7 papers). Jing Dai collaborates with scholars based in China, United States and Australia. Jing Dai's co-authors include Wei Yan, Wenbo Wang, Hui Xu, Fuxiang Zhou, Jin Peng, Kai Gao, Xiaorong Li, Gui Hu, Changwei Lin and Yihang Guo and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Jing Dai

23 papers receiving 294 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jing Dai China 10 172 149 62 23 21 26 294
Kun Zhou China 11 197 1.1× 189 1.3× 53 0.9× 47 2.0× 38 1.8× 26 356
Chunbao Zang China 11 179 1.0× 114 0.8× 83 1.3× 29 1.3× 16 0.8× 25 332
Shuang Tian China 9 129 0.8× 70 0.5× 74 1.2× 24 1.0× 11 0.5× 24 265
Ruiqi Lu China 10 147 0.9× 91 0.6× 121 2.0× 44 1.9× 35 1.7× 24 298
Zhihai Zheng China 12 275 1.6× 220 1.5× 39 0.6× 20 0.9× 24 1.1× 23 385
Youchao Jia China 10 284 1.7× 189 1.3× 63 1.0× 23 1.0× 17 0.8× 16 356
Zhanhong Hu China 10 168 1.0× 55 0.4× 35 0.6× 16 0.7× 14 0.7× 20 300
Sameerah Shaheen Saudi Arabia 10 137 0.8× 75 0.5× 83 1.3× 18 0.8× 28 1.3× 25 314
Kun-Zhe Wu China 13 160 0.9× 118 0.8× 70 1.1× 68 3.0× 47 2.2× 19 319

Countries citing papers authored by Jing Dai

Since Specialization
Citations

This map shows the geographic impact of Jing Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jing Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jing Dai more than expected).

Fields of papers citing papers by Jing Dai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jing Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jing Dai. The network helps show where Jing Dai may publish in the future.

Co-authorship network of co-authors of Jing Dai

This figure shows the co-authorship network connecting the top 25 collaborators of Jing Dai. A scholar is included among the top collaborators of Jing Dai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jing Dai. Jing Dai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fu, Jianfei, Hong Zhu, Shuyu Yang, et al.. (2025). Deubiquitinating enzyme JOSD2 modulates cGAS to facilitate immune evasion in colorectal cancer. OncoImmunology. 14(1). 2590245–2590245.
2.
Fan, Lihong, Siyuan Yin, Yongchang Wei, et al.. (2025). ChREBP-Mediated Choline Deprivation and Chemokine Secretion Shape Tumor-Associated Macrophages to Promote Immune Evasion. Cancer Research. 85(23). 4701–4717.
3.
Zhang, Xin, et al.. (2025). AKR1B1 Inhibits Ferroptosis and Promotes Gastric Cancer Progression via Interacting With STAT3 to Activate SLC7A11. Cell Biology International. 49(4). 374–383. 2 indexed citations
4.
Gong, Jifang, Chang Liu, Jun Yao, et al.. (2024). Efficacy and safety of LM-108, an anti-CCR8 monoclonal antibody, in combination with an anti-PD-1 antibody in patients with gastric cancer: Results from phase 1/2 studies.. Journal of Clinical Oncology. 42(16_suppl). 2504–2504. 5 indexed citations
5.
Li, Xiaoxia, Min Wang, Jing Dai, Huanhuan Liu, & Haili Qin. (2022). Assembled caseins as crosslinkers for tough, adhesive and self-healing hydrogels towards flexible sensors. Journal of Materials Chemistry A. 10(27). 14300–14309. 8 indexed citations
6.
Zhang, Jinyan, et al.. (2022). Comprehensive analysis of GSEC/miR-101-3p/SNX16/PAPOLG axis in hepatocellular carcinoma. PLoS ONE. 17(4). e0267117–e0267117. 14 indexed citations
7.
Chen, Weijia, et al.. (2022). Research on preparation and flame retardancy of melamine-modified flame retardant loofah composites. Journal of Industrial Textiles. 52. 6 indexed citations
9.
Dai, Jing, et al.. (2021). MicroRNA-596 is epigenetically inactivated and suppresses prostatic cancer cell growth and migration via regulating Wnt/β-catenin signaling. Clinical & Translational Oncology. 23(7). 1394–1404. 6 indexed citations
10.
Chen, Lulu, Jin Peng, You Wang, et al.. (2020). Fenofibrate-induced mitochondrial dysfunction and metabolic reprogramming reversal: the anti-tumor effects in gastric carcinoma cells mediated by the PPAR pathway.. PubMed. 12(2). 428–446. 31 indexed citations
11.
Dai, Jing, et al.. (2018). miR‑409‑3p suppresses the proliferation, invasion and migration of tongue squamous cell carcinoma via targeting RDX. Oncology Letters. 16(1). 543–551. 18 indexed citations
12.
Wu, Hao, Runliu Wu, Miao Chen, et al.. (2017). Comprehensive analysis of differentially expressed profiles of lncRNAs and construction of miR-133b mediated ceRNA network in colorectal cancer. Oncotarget. 8(13). 21095–21105. 20 indexed citations
13.
Dai, Jing, Hao Wu, Yi Zhang, et al.. (2016). Negative feedback between TAp63 and Mir-133b mediates colorectal cancer suppression. Oncotarget. 7(52). 87147–87160. 15 indexed citations
14.
Yang, Chunxu, Shimin Zhang, Jie Li, et al.. (2016). MicroRNA-320 regulates the radiosensitivity of cervical cancer cells C33AR by targeting β-catenin. Oncology Letters. 12(6). 4983–4990. 15 indexed citations
15.
Dai, Jing, Wei Wu, Jianyu Zhou, et al.. (2015). Effect of antisense microRNA targeting survivin on rectal cancer HRC-9698 cells and its mechanism.. PubMed. 8(6). 6057–63. 3 indexed citations
16.
Lin, Changwei, Xiaorong Li, Yi Zhang, et al.. (2015). The microRNA feedback regulation of p63 in cancer progression. Oncotarget. 6(11). 8434–8453. 26 indexed citations
17.
Dai, Jing. (2012). Pathogen conservation molecules and PAMP-triggered innate immunity in plants. 1 indexed citations
18.
Dai, Jing. (2011). Green Synthesis of Gold Nanoparticles and Deaggregating Effect of CTAB on Gold Nanoaggregates. Wuji huaxue xuebao. 1 indexed citations
19.
Dai, Jing & Xian Wang. (2007). Immunoregulatory effects of homocysteine on cardiovascular diseases.. PubMed. 59(5). 585–92. 8 indexed citations
20.
Dai, Jing, et al.. (1995). Electrochromic NiOx Film by DC Sputtering. Journal de Physique III. 5(10). 1491–1499. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026